Dogwood Therapeutics Inc (NASDAQ:DWTX) has a beta value of 1.94 and has seen 5.56 million shares traded in the recent trading session. The company, currently valued at $9.83M, closed the recent trade at $7.38 per share which meant it gained $0.78 on the day or 11.82% during that session. The DWTX stock price is -296.75% off its 52-week high price of $29.28 and 78.05% above the 52-week low of $1.62.
Dogwood Therapeutics Inc (NASDAQ:DWTX) trade information
Sporting 11.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the DWTX stock price touched $7.38 or saw a rise of 21.9%. Year-to-date, Dogwood Therapeutics Inc shares have moved 196.39%, while the 5-day performance has seen it change 72.03%. Over the past 30 days, the shares of Dogwood Therapeutics Inc (NASDAQ:DWTX) have changed -37.51%.
Dogwood Therapeutics Inc (DWTX) estimates and forecasts
The company’s shares have gained 59.91% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -2.02% over the past 5 years. Earnings growth for 2025 is a modest 13.86% while over the next 5 years, the company’s earnings are expected to increase by 5.11%.
DWTX Dividends
Dogwood Therapeutics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Dogwood Therapeutics Inc (NASDAQ:DWTX)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.44% shares in the company for having 5.86 shares of worth $45618.0 while later fund manager owns 2.29 shares of worth $17870.0 as of Dec 31, 2024, which makes it owner of about 0.17% of company’s outstanding stock.
